NEW YORK (Reuters Health) - New research shows that babies born to methamphetamine-using moms face much higher risks of serious complications, compared to babies not exposed in the womb to this illegal street drug. Life-threatening pregnancy complications, such as uncontrolled high blood pressure, are also more common among women who use ...More
NEW YORK (Reuters) - In the city that never sleeps there is one increasingly busy nocturnal resident who New York wants to evict -- the bedbug. The city announced plans on Wednesday to spend $500,000 raising awareness of the tiny bloodsucking mites in a bid to kill them off after bedbug ...More
NEW YORK (Reuters Health) - Pregnant women with a history of pregnancy-related diabetes, also called gestational diabetes, have a good chance of developing the condition again, suggests a large new study. Researchers found that the risk of having gestational diabetes during a future pregnancy increases with each previously affected one -- from ...More
HONG KONG (Reuters) - A new diagnostic tool that reduces to two hours the time needed to detect drug-resistant tuberculosis must be made available to populations vulnerable to the disease, a World Health Organization expert said. Asia carries more than half the global caseload of drug resistant TB, which is very ...More
NEW YORK (Reuters Health) - Children who live in damp, water-damaged homes may be more likely than other kids to develop nasal allergies, a new study suggests. Researchers found that of nearly 1,900 Finnish children they followed for six years, those who lived in homes with dampness or mold problems ...More
NEW YORK (Reuters Health) - Children and teenagers exposed to secondhand smoke at home may get poorer grades than their peers from smoke-free homes, a study of Hong Kong students suggests. Secondhand smoke is a well-known health threat to children, being linked to increased risks of asthma, as well as bronchitis ...More
HONG KONG (Reuters) - Researchers in Japan have designed a test to identify patients who are likely to be resistant to imatinib, the standard drug for treating leukemia or cancer of the blood cells. Such a test is important as imatinib resistance occurs usually to relapse patients, who tend to deteriorate ...More
NEW YORK (Reuters) - A decision by a U.S. appeals court could pave the way for cheaper generic forms of Eli Lilly and Co's Gemzar cancer drug to be launched in the United States beginning in mid-November. Many industry analysts have expected Gemzar to lose U.S. marketing exclusivity ...More
